---

Next generation sequencing: A promising tool to explore the personalized medicine in understanding the neurodegenerative diseases

---

Review Article

Author Details : Gayatri Gawade*, Sameer A Chaudhary, Sapana Chaudhary, Sakshi Rawat, Anwar L Bilgrami, Meghana Padwal

Volume : 8, Issue : 3, Year : 2021

Article Page : 153-162

https://doi.org/10.18231/j.ijcbr.2021.034

Suggest article by email

Get Permission

---

Abstract

Despite the various advances made in the diagnosis and treatments, the incidence of the neurodegenerative diseases has increased manifold during the last few decades. The inadequate early diagnosis appears to be the main reason behind the significant increase in the number of neurodegenerative diseases and their poor prognosis. Next generation sequencing has been discovered as an effective and indicative tool, especially for chronic and severe neurological illnesses, such as Parkinson and Alzheimer. As a clinical apparatus, next generation sequencing will help in creating explicit hereditary focuses for the treatment of neurodegenerative diseases and finding new diagnostic biomarkers. Next-generation sequencing has been demonstrated to be increasingly productive, practical and utilizes molecular determination, which determines biomarkers and different targets quicker and efficiently than the other established diagnostic methods. There is a desperate requirement to change the current treatment and medication regimes in order to make better prognosis for the patients. This can be accomplished by utilizing customized drug to treat neurodegenerative diseases and using next generation sequencing with personal medicine as the method for specialized treatment of the patients suffering from neurodegenerative disorders.
 

Keywords: Neurodegenerative diseases, Personalized medicine, Next generation sequencing (NGS), Diagnosis, Biomarkers.

How to cite : Gawade G, Chaudhary S A, Chaudhary S, Rawat S, Bilgrami A L, Padwal M, Next generation sequencing: A promising tool to explore the personalized medicine in understanding the neurodegenerative diseases. Int J Clin Biochem Res 2021;8(3):153-162

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.